CCL2 and Alzheimer disease: Increased serum CCL2 has been reported as potential aggravator of FTD pathology and TREM2 mutation has been suggested with development of FTD like phenotype previously73–75, and low frequency variants in this gene have been reported to be associated with AD and FTD.76–79